| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 405 | NLS932AF405 | |||
| Alexa Fluor 488 | NLS932AF488 | |||
| Alexa Fluor 647 | NLS932AF647 | |||
| Alexa Fluor 700 | NLS932AF700 | |||
| Biotin | NLS932B | |||
| DyLight 405 | NLS932V | |||
| DyLight 488 | NLS932G | |||
| DyLight 550 | NLS932R | |||
| DyLight 650 | NLS932C | |||
| FITC | NLS932F | |||
| HRP | NLS932H | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 405 | NLS932AF405 | |||
| Alexa Fluor 488 | NLS932AF488 | |||
| Alexa Fluor 647 | NLS932AF647 | |||
| Alexa Fluor 700 | NLS932AF700 | |||
| DyLight 405 | NLS932V | |||
| DyLight 488 | NLS932G | |||
| DyLight 550 | NLS932R | |||
| DyLight 650 | NLS932C | |||
| FITC | NLS932F | |||
| HRP | NLS932H | |||
![Knockdown Validated: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Melatonin Receptor 1B Antibody [NLS932] - Analysis for collagen I, fibronectin, and Alpha-smooth muscle actin (Alpha-SMA). Cells were treated with TGF-B1 (5 ng/mL) for 24 h after preincubation with Veh or Mel (0.1 mM or 1 mM) for 30 min. The graphs show the results of quantitative analysis of collagen I. Melatonin Prevents Transforming Growth Factor-B1 Stimulated Transdifferentiation of Renal Interstitial Fibroblasts to Myofibroblasts by Suppressing Reactive Oxygen Species-Dependent Mechanisms. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31906396/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Western-Blot-NLS932-img0012.jpg "<b>Genetic Strategies Validation. </b>Knockdown Validated: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Melatonin Receptor 1B Antibody [NLS932] - Analysis for collagen I, fibronectin, and Alpha-smooth muscle actin (Alpha-SMA). Cells were treated with TGF-B1 (5 ng/mL) for 24 h after preincubation with Veh or Mel (0.1 mM or 1 mM) for 30 min. The graphs show the results of quantitative analysis of collagen I. Melatonin Prevents Transforming Growth Factor-B1 Stimulated Transdifferentiation of Renal Interstitial Fibroblasts to Myofibroblasts by Suppressing Reactive Oxygen Species-Dependent Mechanisms. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31906396/) licensed under a CC-BY license.")
![<b>Genetic Strategies Validation. </b>Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Melatonin receptor type 1 B (MTR1B) in rat tissues fixed in paraformaldehyde and embedded in paraffin. A,B-brain, C-prostate. Image from verified customer review.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0008.jpg)
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term diabetic treated with MLT (MD1) Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0009.jpg)
![Western Blot: Melatonin Receptor 1B Antibody [NLS932] - Analysis of 1) HepG2 and 2) A431.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Western-Blot-NLS932-img0003.jpg)
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term control (C1). Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0011.jpg)
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Analysis of Human Brain. 8 ug/ ml.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0006.jpg)
![Immunohistochemistry: Melatonin Receptor 1B Antibody [NLS932] - Analysis of Human Brain using Fast Red with hematoxylin counterstain.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-NLS932-img0004.jpg)
![Immunohistochemistry: Melatonin Receptor 1B Antibody [NLS932] - Staining of Mouse Brain.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-NLS932-img0005.jpg)
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term control treated with MLT (M1). Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0010.jpg)
![Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-310202416114744.jpg)
![Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-310202416114737.jpg)
![Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-310202416121978.jpg)
![Western Blot: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Effects of luzindole on inhibitory action of melatonin on TGF-beta 1-stimulated proliferation & activation in renal interstitial fibroblasts. (A) Reverse transcription-polymerase chain reaction analysis of melatonin receptor type 1A (MT1) & type 1B (MT2) in NRK-49F cells. (B) NRK-49F cells were treated with with TGF-beta 1 (5 ng/mL) after preincubation with vehicle (Veh) or melatonin (Mel; 1mM) in the presence or absence of luzindole (Luz; 100 μM) for 30 min. Cell viability was assessed using CCK-8 assay at 0, 24, & 48 h. The OD was measured at 450 nm. (C) Western blot analysis for alpha -SMA & p-Smad2/3. Cells were treated with TGF-beta 1 (5 ng/mL) for 24 h after preincubation with Veh or Mel (1 mM) in the presence or absence of luzindole (Luz; 20 μM or 100 μM) for 30 min. The graphs show the results of quantitative analysis of alpha -SMA (D) & p-Smad2/3 (E). ** p < 0.01 & *** p < 0.001 vs. Veh-treated cells. #p < 0.05 vs. TGF-beta 1-treated cells. NS: not significant. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31906396), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-3102024161367.jpg)
![Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-310202416121951.jpg)
![Immunohistochemistry: Melatonin Receptor 1B Antibody [NBP3-14401] - Immunohistochemistry of retina](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-NBP3-14401-img0005.jpg "Immunohistochemistry: Melatonin Receptor 1B Antibody [NBP3-14401] - Immunohistochemistry of retina")
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NBP3-14401] - Immunohistochemistry of formalin-fixed, paraffin-embedded human retina after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NBP3-14401-img0001.jpg)
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NBP3-14401] - Immunohistochemistry of formalin-fixed, paraffin-embedded human brain after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NBP3-14401-img0002.jpg)
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NBP3-14401] - Immunohistochemistry of formalin-fixed, paraffin-embedded human skin melanoma after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NBP3-14401-img0003.jpg)
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NBP3-14401] - Immunohistochemistry of formalin-fixed, paraffin-embedded human eye after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NBP3-14401-img0004.jpg)
![Immunohistochemistry: Melatonin Receptor 1B Antibody [NBP3-14401] - Immunohistochemistry of brain, glioblastoma,](http://images.novusbio.com/fullsize/Melatonin Receptor 1B Antibody-Immunohistochemistry-NBP3-14401-img0006.jpg)
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NBP3-17202] - Staining of human retina shows strong cytoplasmic positivity in nerve fiber layer.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NBP3-17202-img0001.jpg "Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NBP3-17202] - Staining of human retina shows strong cytoplasmic positivity in nerve fiber layer.")
![Western Blot: Melatonin Receptor 1B Antibody [NBP2-84160] - WB Suggested Anti-MTNR1B Antibody. Titration: 1.0 ug/ml. Positive Control: HepG2 Whole Cell](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Western-Blot-NBP2-84160-img0001.jpg "Western Blot: Melatonin Receptor 1B Antibody [NBP2-84160] - WB Suggested Anti-MTNR1B Antibody. Titration: 1.0 ug/ml. Positive Control: HepG2 Whole Cell")
![ELISA: Human Melatonin Receptor 1B - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39833] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-39833_human-melatonin-receptor-1b-ready-to-use-elisa-kit-2110202415302980.png "ELISA: Human Melatonin Receptor 1B - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39833] - Standard Curve Reference")
![ELISA: Human Melatonin Receptor 1B ELISA Kit (Colorimetric) [NBP3-39832] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-39832_human-melatonin-receptor-1b-elisa-kit-colorimetric-2110202415264334.png "ELISA: Human Melatonin Receptor 1B ELISA Kit (Colorimetric) [NBP3-39832] - Standard Curve Reference")